— Know what they know.
Not Investment Advice

TYME NASDAQ

Tyme Technologies, Inc.
1W: +26.9% 1M: -6.7% 3M: +24.3% 1Y: -70.1% 3Y: -80.6% 5Y: -95.5%
$0.31
Last traded 2022-09-16 — delisted
NASDAQ · Healthcare · Biotechnology

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$26M +6.3% ▲
Net Income
-$22M +25.2% ▲
EPS (Diluted)
$-0.13 +40.9% ▲
EBITDA
-$22M +13.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$0$0$0
Gross Margin—————
R&D Expenses$9M$15M$13M$17M$13M
SG&A Expenses$11M$15M$13M$10M$10M
Operating Expenses$19M$29M$26M$27M$23M
Operating Income-$19M-$32M-$26M-$27M-$26M
Operating Margin—————
Interest Expense$0$0$114K$97K$70K
Income Before Tax-$19M-$33M-$22M-$29M-$24M
Tax Expense$390K$0$0$0-$2M
Net Income-$19M-$33M-$22M-$29M-$22M
Net Margin—————
EPS (Diluted)$-0.21$-0.32$-0.19$-0.22$-0.13
EBITDA-$19.4B-$32M-$22M-$29M-$22M
Shares Outstanding91M102M115M134M172M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms